A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Clinical Trials

Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy

Billy Boyle, co-founder and CEO at Owlstone Medical, said: “Results from Phase 1 of the EVOLUTION trial demonstrated the relevance of the molecular pathway targeted by D5-EthGlu and provided crucial evidence to support further test development. With the recruitment of the first patient into Phase 2, we are excited to continue to progress a test that has the potential to transform lung cancer diagnosis by substantially increasing the uptake of testing, leading to more cases of lung cancer being caught early and significantly reducing mortality and costs. Our nodule management test also holds the potential for more effective identification of benign nodules, reducing unnecessary biopsies and surgery.”

Salubris Biotherapeutics Presents Positive 6-Month Data from Phase 1b Clinical Trial of JK07 in Late-Breaking Session at The Heart Failure Society of America Annual Meeting 2023

The data were presented in a late breaking oral session during the Heart Failure Society of America Annual Scientific Meeting 2023. JK07 is the first investigational antibody fusion protein and first selective ErbB4 agonist to enter clinical development for heart failure. Heart failure is a leading cause of morbidity and mortality globally, with estimates of more than 6 million patients affected by HFrEF and HFpEF in the US.

Biotechnology News

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

XRHealth Secures $10M in Funding

XRHealth, the gateway to the healthcare metaverse,  announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The funding was backed by

Market Reports

Advancements in Imaging

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

6 Ways to Level-up Your Clinic's Hygiene

6 Ways to Level-up Your Clinic’s Hygiene

Today, clinic hygiene is more important than ever. With the spread of COVID-19, healthcare organizations have had to make serious changes to their hygiene practices

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.